Literature DB >> 20173103

Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications.

Jennifer R Kohr1, Peter R Eby, Kimberly H Allison, Wendy B DeMartini, Robert L Gutierrez, Sue Peacock, Constance D Lehman.   

Abstract

PURPOSE: To determine if patients with fewer than three foci of atypical ductal hyperplasia (ADH) who have all of their calcifications removed after stereotactic 9- or 11-gauge vacuum-assisted breast biopsy (VABB) have a rate of upgrade to malignancy that is sufficiently low to obviate surgical excision.
MATERIALS AND METHODS: An institutional review board-approved, HIPAA-compliant retrospective review of 991 cases of consecutive 9- or 11-gauge stereotactic VABB performed during a 65-month period revealed 147 cases of atypia. One pathologist performed a blinded review of the results of procedures performed to assess for calcifications and confirmed ADH in 101 cases with subsequent surgical excision. Each large duct or terminal duct-lobular unit containing ADH was considered a focus and counted. Postbiopsy mammograms were reviewed to determine whether all calcifications were removed. Upgrade to malignancy was determined from excisional biopsy pathology reports. Upgrade rates as a function of both number of foci and presence or absence of residual calcifications were calculated and compared by using chi(2) tests.
RESULTS: Upgrade to malignancy occurred in 20 (19.8%) of the 101 cases. The upgrade rate was significantly higher in cases of three or more foci of ADH (15 [28%] of 53 cases) than in cases of fewer than three foci (five [10%] of 48 cases) (P = .02). Upgrade rates were similar, regardless of whether all mammographic calcifications were removed (seven [17%] of 41 cases) or all were not removed (nine [20%] of 45 cases) (P = .77). Upgrade occurred in two (12%) of 17 cases in which there were fewer than three ADH foci and all calcifications were removed.
CONCLUSION: The upgrade rate is significantly higher when ADH involves at least three foci. Surgical excision is recommended even when ADH involves fewer than three foci and all mammographic calcifications have been removed, because the upgrade rate is 12%. Copyright RSNA, 2010

Entities:  

Mesh:

Year:  2010        PMID: 20173103     DOI: 10.1148/radiol.09091406

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  19 in total

1.  Early Breast Cancer Precursor Lesions: Lessons Learned from Molecular and Clinical Studies.

Authors:  Hans-Peter Sinn; Zeinab Elsawaf; Birgit Helmchen; Sebastian Aulmann
Journal:  Breast Care (Basel)       Date:  2010-08-23       Impact factor: 2.860

2.  Minimally Invasive Biopsy Methods - Diagnostics or Therapy? Personal Opinion and Review of the Literature.

Authors:  Ute Kettritz
Journal:  Breast Care (Basel)       Date:  2011-04-29       Impact factor: 2.860

3.  Values of pathological analysis of lost tissue fragments in the vacuum canister during a vacuum-assisted stereotactic biopsy of the breast.

Authors:  M El Khoury; B Mesurolle; A Omeroglu; A Aldis; E Kao
Journal:  Br J Radiol       Date:  2013-03-21       Impact factor: 3.039

4.  Diagnostic underestimation of atypical ductal hyperplasia and ductal carcinoma in situ at percutaneous core needle and vacuum-assisted biopsies of the breast in a Brazilian reference institution.

Authors:  Gustavo Machado Badan; Decio Roveda Júnior; Sebastião Piato; Eduardo de Faria Castro Fleury; Mário Sérgio Dantas Campos; Carlos Alberto Ferreira Pecci; Felipe Augusto Trocoli Ferreira; Camila D'Ávila
Journal:  Radiol Bras       Date:  2016 Jan-Feb

5.  Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution.

Authors:  Xiaoxian Li; Zhongliang Ma; Toncred M Styblo; Cletus A Arciero; Haibo Wang; Michael A Cohen
Journal:  Breast Cancer Res Treat       Date:  2020-10-17       Impact factor: 4.872

Review 6.  How Do We Approach Benign Proliferative Lesions?

Authors:  Faina Nakhlis
Journal:  Curr Oncol Rep       Date:  2018-03-23       Impact factor: 5.075

7.  Vacuum-assisted stereotactic breast biopsy in the diagnosis and management of suspicious microcalcifications.

Authors:  Gül Esen; Burçin Tutar; Cihan Uras; Zerrin Calay; Ümit İnce; Onur Tutar
Journal:  Diagn Interv Radiol       Date:  2016 Jul-Aug       Impact factor: 2.630

8.  Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH).

Authors:  Keiko Tsuchiya; Naoko Mori; David V Schacht; Deepa Sheth; Gregory S Karczmar; Gillian M Newstead; Hiroyuki Abe
Journal:  J Magn Reson Imaging       Date:  2017-03-10       Impact factor: 4.813

Review 9.  Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review.

Authors:  Kelly L Mooney; Lawrence W Bassett; Sophia K Apple
Journal:  Mod Pathol       Date:  2016-08-19       Impact factor: 7.842

10.  Active surveillance of women diagnosed with atypical ductal hyperplasia on core needle biopsy may spare many women potentially unnecessary surgery, but at the risk of undertreatment for a minority: 10-year surgical outcomes of 114 consecutive cases from a single center.

Authors:  Gelareh Farshid; Suzanne Edwards; James Kollias; Peter Grantley Gill
Journal:  Mod Pathol       Date:  2017-11-03       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.